OTC Markets EXMKT - Delayed Quote USD

Capha Pharmaceuticals Inc. (FPSUF)

Compare
0.0001
0.0000
(0.00%)
At close: November 18 at 3:00:00 PM EST
Loading Chart for FPSUF
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 588
  • Avg. Volume 0
  • Market Cap (intraday) 6,443
  • Beta (5Y Monthly) 64.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Capha Pharmaceuticals Inc. does not have significant operations. It intends to explore opportunities in the pharmaceutical distribution business. The company was formerly known as FPS Pharma Inc. and changed its name to Capha Pharmaceuticals Inc. in January 2017. The company is based in West Kelowna, Canada.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FPSUF

View More

Performance Overview: FPSUF

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

FPSUF
0.00%
S&P 500
1.52%

1-Year Return

FPSUF
0.00%
S&P 500
25.82%

3-Year Return

FPSUF
0.00%
S&P 500
28.61%

5-Year Return

FPSUF
900.00%
S&P 500
80.80%

Compare To: FPSUF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FPSUF

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,331.62%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -70.84k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.42k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -43.41k

Research Analysis: FPSUF

View More

Company Insights: FPSUF

Research Reports: FPSUF

View More

People Also Watch